Dosimetric and LETd comparison of horizontal port and gantry carbon-ion radiotherapy for early-stage non–small cell lung cancer: an exploratory study
Radiation Oncology Journal · 24.08.2026
DOI: 10.3857/roj.2026.00080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation Oncology Journal, online erschienen am 24.08.2026. Verfasst von Seung-Hyeop Baek und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Yonsei Cancer Center, Seoul, Republic of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Yonsei Cancer Center, Seoul, Republic of Korea.
- Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
- Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Zitieren
APA
Baek, S. H., Furutani, K. M., Park, S., Park, J. C., Han, M. C., Kim, C., Kim, J. S., Beltran, C. J., Kim, K. H., & Hong, C. S. (2026). Dosimetric and LETd comparison of horizontal port and gantry carbon-ion radiotherapy for early-stage non–small cell lung cancer: an exploratory study. Radiation Oncology Journal. https://doi.org/10.3857/roj.2026.00080
Vancouver
Baek SH, Furutani KM, Park S, Park JC, Han MC, Kim C, et al. Dosimetric and LETd comparison of horizontal port and gantry carbon-ion radiotherapy for early-stage non–small cell lung cancer: an exploratory study. Radiation Oncology Journal. 2026. doi:10.3857/roj.2026.00080
BibTeX
@article{Baek2026,
author = {Baek, Seung-Hyeop and Furutani, Keith M and Park, Seyjoon and Park, Justin Chunjoo and Han, Min Cheol and Kim, Changhwan and Kim, Jin Sung and Beltran, Chris J and Kim, Kyung Hwan and Hong, Chae-Seon},
title = {Dosimetric and LETd comparison of horizontal port and gantry carbon-ion radiotherapy for early-stage non–small cell lung cancer: an exploratory study},
journal = {Radiation Oncology Journal},
year = {2026},
doi = {10.3857/roj.2026.00080}
}
EUVIMED